{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "104888", "DateCompleted": {"Year": "1979", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0014-9446", "JournalIssue": {"Volume": "38", "Issue": "2", "PubDate": {"Year": "1979", "Month": "Feb"}}, "Title": "Federation proceedings", "ISOAbbreviation": "Fed Proc"}, "ArticleTitle": "Bronchial mucosal permeability.", "Pagination": {"StartPage": "197", "EndPage": "201", "MedlinePgn": "197-201"}, "Abstract": {"AbstractText": ["The tracheobronchial epithelium has well-developed tight junctions which on a morphologic basis should be markedly resistant to penetration by protein molecules. Despite this, antigen inhalation in monkeys allergic to Ascaris suum results in the rapid onset of pulmonary physiologic changes. Recent studies in man and animals have shown that a substantial number of mast cells exist in the bronchial lumen and epithelium. We suggest that antigen-antibody interaction initially occurs on these superficial mast cells leading to mediator release and the stimulation of airway irritant receptors. Antigen challenge also results in increased epithelial permeability to protein in the Ascaris-allergic monkey, and from studies on guinea pigs we suggest that this is due to alterations in the tight junctions. Antigen challenge in the monkey also produces increased permeability to labeled histamine and hyperresponsiveness to low concentrations of histamine. We suggest that the apparent airway hyperreactivity to inhaled histamine seen after inhalation of ozone, and NO2, or after upper respiratory infections could be due to damage to epithelial tight junctions. The resultant increase in mucosal permeability would result in an increased amount of histamine reaching airway smooth muscle for a given inhaled concentration."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Hogg", "ForeName": "J C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Par\u00e9", "ForeName": "P D", "Initials": "PD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Boucher", "ForeName": "R C", "Initials": "RC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Fed Proc", "NlmUniqueID": "0372771", "ISSNLinking": "0014-9446"}, "ChemicalList": [{"RegistryNumber": "820484N8I3", "NameOfSubstance": "Histamine"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology"], "DescriptorName": "Ascaris"}, {"QualifierName": ["physiology"], "DescriptorName": "Bronchi"}, {"QualifierName": ["immunology", "physiopathology"], "DescriptorName": "Bronchial Spasm"}, {"QualifierName": [], "DescriptorName": "Cell Membrane Permeability"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Haplorhini"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Histamine"}, {"QualifierName": ["immunology"], "DescriptorName": "Mast Cells"}, {"QualifierName": ["physiology"], "DescriptorName": "Mucous Membrane"}, {"QualifierName": ["physiology"], "DescriptorName": "Reflex"}, {"QualifierName": [], "DescriptorName": "Respiration"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1979", "Month": "2", "Day": "1"}, {"Year": "1979", "Month": "2", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1979", "Month": "2", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["104888"]}}], "PubmedBookArticle": []}